CEPI-backed studies will analyse blood samples from thousands of people who have already been vaccinated against Zaire ebolavirus, with first results expected within months CEPI is providing US$4.17 million to four research projects designed to assess whether vaccines already or previously licensed against Zaire ebolavirus—including Ervebo—could offer protection against Bundibugyo ebolavirus, the virus behind the […]
